- CA$300.17m
- CA$252.95m
- $16.10m
NASDAQ RESUMED AT 09:50 AM
Brief: Profound Medical Announces Pricing Of Offering Of Common Shares
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:49 AM
Brief: Profound Medical Anticipates Total Revenues For Q4 To Be About $2.7 Million
Brief: Profound Medical And Radnet Sign The First-Ever U.S. Multi-Center Commercial Agreement For Tulsa-Pro®
Canada Research Roundup: Encana, Hydro One, OrganiGram Holdings
Brief: Profound Medical Announces Health Canada Approval Of Tulsa-Pro®
Brief: Profound Medical Posts Qtrly Loss Per Share Of $0.57
Brief: Profound Medical Announces Nasdaq Listing
Brief: Profound Medical Corp. Announces Share Consolidation
Brief: Profound Medical Corp Files For Mixed Shelf Of Up To $100 Mln – SEC Filing
Brief: Profound Medical Proposes New MJDS Registration For Its Proposed U.S. Listing
Brief: Profound Medical Announces Pricing Of Offerings
Brief: Profound Medical Announces Proposed Offerings Of Units
Canada Stocks: TSX futures up on hopes of easing trade tensions
Brief: Profound Medical Receives U.S. FDA 510(K) Clearance For Tulsa-Pro®
Brief: Profound Medical's Board Size Increased To Seven Members
Brief: Profound Medical Announces Second Quarter 2019 Financial Results
Brief: Profound Medical Q1 Loss Per Share C$0.03